Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharmaceutical Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN106432103A reveals Au/TiO2 catalyzed quinazolinone synthesis. Offers high yield, recyclable catalyst, and scalable process for reliable pharmaceutical intermediates supplier partnerships.
Patent CN118459357A reveals a novel refining method for cinacalcet hydrochloride intermediates ensuring high purity and reduced supply chain complexity for global manufacturers.
Novel three-step synthesis improves purity and yield for pharmaceutical intermediates. Reduces cost and enhances supply chain reliability for global buyers.
Patent CN118930500A reveals a one-step synthesis method offering high yield and simplified operations for antifungal intermediates, ensuring supply chain stability.
Novel synthetic route from (E)-Nerolidol avoiding difficult isomer separation. High purity teprenone precursor with cost-effective supply chain solutions.
Patent CN101535467B discloses a novel biocatalytic route for chiral hydroxy acids using Fusarium proliferatum ECU2002, offering high optical purity and scalable manufacturing solutions.
Patent CN107354477A reveals green electrochemical synthesis. Offers cost reduction and supply chain reliability for pharmaceutical intermediates manufacturing.
Patent CN104230987B reveals high-yield route for Tenofovir intermediates reducing cost and improving supply chain reliability for pharmaceutical manufacturers.
Novel Ugi-based method for indole-dipyrrolemethane derivatives. Metal-free, high yield, scalable for pharma intermediates. Reliable supply chain partner.
Patent CN102321004A details a novel L-(+)-selenomethionine synthesis using dimethyl sulfate. This report analyzes cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN106631875A details a novel nitrogen mustard derivative synthesis. This report analyzes cost reduction in API manufacturing and supply chain reliability for pharmaceutical intermediates.
Patent CN102321004A reveals a novel L-(+)-selenomethionine synthesis using dimethyl sulfate. This report analyzes cost reduction and supply chain reliability for nutritional ingredient manufacturers.
Patent CN1257468A reveals novel Cp*-metal catalysts for efficient asymmetric transfer hydrogenation, offering significant cost reduction in pharmaceutical manufacturing and safer processing.
Patent CN111423391A reveals a cost-effective fluorination route for florfenicol intermediates using tetrafluoroethylene, offering significant supply chain advantages.
Patent CN107857727A details a novel Lewis acid method for Bedaquiline, offering higher yields and safer supply chains for global pharmaceutical manufacturers.
Patent CN1962608A reveals a high-selectivity Raney-Ni method for 3,4-dichloroaniline. Achieve superior purity and cost efficiency in pharmaceutical intermediates manufacturing.
Patent CN108276233A reveals a novel iron-catalyzed amide synthesis route offering cost reduction in pharmaceutical intermediates manufacturing and enhanced supply chain reliability.
Patent CN104130194A reveals a green catalytic hydrogenation route for 5-Amino-2-benzimidazolinone, offering superior purity and supply chain reliability for pharmaceutical manufacturers.
Novel hydrolysis-esterification route for high-purity Cefathiamidine. Reduces costs and improves supply chain stability for pharmaceutical manufacturers.
Patent CN102134265A details a novel 8-step synthesis from estrone. This route offers significant cost reduction and supply chain reliability for pharmaceutical intermediates.